Repligen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.About RGEN
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.
CEOOlivier Dominique Loeillot
CEOOlivier Dominique Loeillot
Employees1,778
Employees1,778
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded1981
Founded1981
Employees1,778
Employees1,778
RGEN Key Statistics
Market cap9.33B
Market cap9.33B
Price-Earnings ratio6.48K
Price-Earnings ratio6.48K
Dividend yield—
Dividend yield—
Average volume757.41K
Average volume757.41K
High today$167.67
High today$167.67
Low today$161.75
Low today$161.75
Open price$165.51
Open price$165.51
Volume573.23K
Volume573.23K
52 Week high$182.52
52 Week high$182.52
52 Week low$102.97
52 Week low$102.97
Stock Snapshot
The current Repligen(RGEN) stock price is $165.76, with a market capitalization of 9.33B. The stock trades at a price-to-earnings (P/E) ratio of 6479.38.
During the trading session on 2025-12-05, Repligen(RGEN) shares reached a daily high of $167.67 and a low of $161.75. At a current price of $165.76, the stock is +2.5% higher than the low and still -1.1% under the high.
Trading activity shows a volume of 573.23K, compared to an average daily volume of 757.41K.
Over the past 52 weeks, Repligen(RGEN) stock has traded between a high of $182.52 and a low of $102.97.
Over the past 52 weeks, Repligen(RGEN) stock has traded between a high of $182.52 and a low of $102.97.
Analyst ratings
78%
of 23 ratingsBuy
78.3%
Hold
21.7%
Sell
0%
People also own
Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.